摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(5-bromofur-2-yl)-2-bromo-2-nitroethene | 35950-55-1

中文名称
——
中文别名
——
英文名称
1-(5-bromofur-2-yl)-2-bromo-2-nitroethene
英文别名
(Z)-2-(2-bromo-2-nitroethenyl)-5-bromofuran;(Z)-2-bromo-5-(2-bromo-2-nitrovinyl)furan;5-bromo-2-(2-bromo-2-nitroethenyl)furan;(Z)-1-bromo-2-(5-bromofuran-2-yl)-1-nitroethene;2-bromo-5-(2-bromo-2-nitrovinyl)-furan;Furvina;2-bromo-5-[(Z)-2-bromo-2-nitroethenyl]furan
1-(5-bromofur-2-yl)-2-bromo-2-nitroethene化学式
CAS
35950-55-1
化学式
C6H3Br2NO3
mdl
——
分子量
296.903
InChiKey
MJPPGVVIDGQOQT-HWKANZROSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    305.2±42.0 °C(Predicted)
  • 密度:
    2.141±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    59
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2932190090

SDS

SDS:87567da926e7cf5d3180efaf4d0966e0
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(5-bromofur-2-yl)-2-bromo-2-nitroethene四(三苯基膦)钯 potassium phosphate 作用下, 以 甲苯 为溶剂, 反应 8.0h, 生成
    参考文献:
    名称:
    Synthesis of 2-(2-Arylethenyl)-5-arylfurans by Regioselective Palladium(0)-Catalyzed Coupling Reactions of 2-(2-Bromo-2-nitroethenyl)-5-bromofuran
    摘要:
    2-(2-溴-2-硝基乙烯基)-5-溴呋喃的铃木反应,易于从糠醛获得,导致对呋喃部分的区域选择性攻击。烯基部分可以在第二次铃木反应中进行官能团化。
    DOI:
    10.1055/s-2006-950271
  • 作为产物:
    描述:
    β-<5-Brom-furyl-2>-α,β-dibrom-nitro-ethylen 在 potassium acetate 作用下, 以 乙醇 为溶剂, 反应 0.17h, 以68%的产率得到1-(5-bromofur-2-yl)-2-bromo-2-nitroethene
    参考文献:
    名称:
    Furan-containing gem-bromonitroethenes: Synthesis and reaction with morpholine
    摘要:
    The first time the representative of furan-containing gem-bromonitroethenes 5-nitro-2-(2-bromo-2-nitro-ethenyl)furan was synthesized by bromination of 5-nitro-2-(2-nitroethenyl)furan followed by dehydrohalogenation of the dibromide. Morpholine adducts of the synthesized beta-substituted gem-bromonitroethene and its analog with a 5-bromo-2-furyl substituent were obtained. The structures of the gem-bromonitroethenes and aza adducts were characterized by spectral methods (IR, UV, H-1, and C-13-{H-1} NMR, including H-1-C-13 HMQC and HMBC).
    DOI:
    10.1134/s1070363215060110
点击查看最新优质反应信息

文献信息

  • Organocatalytic enantioselective synthesis of dihydronaphthofurans and dihydrobenzofurans: reaction development and insights into stereoselectivity
    作者:Zeynep Dilşad Susam、Bilge Deniz Özcan、Enis Kurtkaya、Erol Yildirim、Cihangir Tanyeli
    DOI:10.1039/d2ob01571d
    日期:——
    Squaramide/cinchona alkaloid-derived bifunctional organocatalysts are in high demand in asymmetric transformations. Bifunctional quinine-derived sterically encumbered squaramide (H-bond donor) organocatalysts were used to catalyze the asymmetric Friedel–Crafts/SN2 type domino reaction of (Z)-α-bromonitroalkenes and α/β-naphthols and phenol derivatives to generate enantiomerically enriched dihydronaphthofuran
    Squaramide/金鸡纳生物碱衍生的双功能有机催化剂在不对称转化中有很高的需求。双功能奎宁衍生的空间阻碍角酰胺(H 键供体)有机催化剂用于催化不对称 Friedel–Crafts/S N 2 型多米诺反应 ( Z)-α-溴硝基烯烃和 α/β-萘酚和苯酚衍生物,分别生成对映体富集的二氢萘并呋喃 (DHN) 和二氢苯并呋喃 (DHB) 衍生物。与文献中已知的方法相比,在温和条件下以相对较低的催化剂负载量 (5 mol%) 获得了高达 >99% ee 的目标加合物。此外,还进行了密度泛函理论 (DFT) 计算以确定可能的结果,解释了立体选择性的起源。据发现,Friedel-Crafts 步骤中反式构象的 π 堆叠相互作用比顺式构象稳定 0.79 kcal mol -1。
  • METHOD FOR OBTAINING 2-BROMO-5-(2-BROMO-2-NITROVINYL)-FURAN
    申请人:Centro De Bioactivos Quimicos (CBQ)
    公开号:EP1249449A1
    公开(公告)日:2002-10-16
    The present invention refers to a new procedure for obtaining and purifying 2-bromo-5-(2-bromo-2-nitrovinyl)-furan in one reaction step starting with 2-nitrovinylfuran, and maintains high indexes of purity and an appropriate yield. The process involves the direct bromination of 2-nitrovinylfuran using charcoal from the beginning of the reaction, followed by the neutralization and dehydrobromination using pyridine, and finally crystallizing and purifying the product obtained with ethanol and charcoal. With the new procedure it is possible to reduce the time of obtaining the final product, the reaction becomes endothermic instead of exothermic, which facilitates the work of the operators and allows for the scaling up of the reaction to superior levels. The process significantly decreases the amount of chemicals in the reaction, some of them with toxic properties. Also the environmental negative impact from the process is diminished as the emission of the bromine vapors and other substances to the environment are eliminated and the residual liquids are cut in half.
    本发明是指一种以 2-硝基乙烯基呋喃为原料,通过一个反应步骤获得和纯化 2-溴-5-(2-溴-2-硝基乙烯基)-呋喃,并保持高纯度指标和适当收率的新工艺。 该工艺包括在反应开始时使用木炭直接溴化 2-硝基乙烯基呋喃,然后使用吡啶中和并脱氢溴化,最后使用乙醇和木炭结晶并纯化得到的产物。 采用新工艺可以缩短获得最终产品的时间,反应由放热变为内热,从而方便了操作人员的工作,并使反应规模达到更高水平。 该工艺大大减少了反应中化学物质的用量,其中一些化学物质具有毒性。此外,由于消除了向环境排放溴蒸汽和其他物质,残留液体也减少了一半,该工艺对环境的负面影响也随之降低。
  • Cochleate with only one mamp
    申请人:Instituto Finlay, Centro de Investigacion-Produccion de vacunas y sueros
    公开号:EP2689775A1
    公开(公告)日:2014-01-29
    The present invention relates to the field of immunology, specifically the branch of adjuvants and vaccines. The technical objective is to obtain adjuvants based on cochlear structures that are neither proteolipidic nor lipidic and that contain microbe-associated molecular patterns (MAMPs) and have the optional addition of antibiotics/chemotherapeutic agents with the aim of using them as vaccine adjuvants for the treatment and prevention of veterinary and human diseases. Additionally, these would be used as immunopotentiators in veterinary and human formulations. It is also a technical objective of this patent to utilize the said new cochlear structures with particular antigens added or liberated in vivo for the combined effect of immunopotentiation and antibiotics/chemotherapeutic agents in infectious diseases to obtain therapeutic vaccines for veterinary and human use in the pharmaceutical industry. The invention also relates to the method for obtaining sterile cochlear structures.
    本发明涉及免疫学领域,特别是佐剂和疫苗分支。其技术目标是获得基于耳蜗结构的佐剂,这种佐剂既不是蛋白脂质的,也不是脂质的,含有微生物相关分子模式(MAMPs),并可选择添加抗生素/化疗药物,目的是将其用作治疗和预防兽医和人类疾病的疫苗佐剂。此外,它们还可用作兽医和人类配方中的免疫促进剂。本专利的另一个技术目标是利用上述新的耳蜗结构,在体内添加或释放特定抗原,在传染病中发挥免疫增强剂和抗生素/化疗药物的联合作用,以获得用于制药业的兽用和人用治疗疫苗。本发明还涉及获得无菌耳蜗结构的方法。
  • Method for obtaining 2-bromo-5-(2-bromo-2-nitrovinyl)-furan
    申请人:——
    公开号:US20030130529A1
    公开(公告)日:2003-07-10
    The present invention refers to a new procedure for obtaining and purifying 2-bromo-5-(2-bromo-2-nitrovinyl)-furan in one reaction step starting with 2-nitrovinylfuran, and maintains high indexes of purity and an appropriate yield. The process involves the direct bromination of 2-nitrovinylfuran using charcoal from the beginning of the reaction, followed by the neutralization and dehydrobromination using pyridine, and finally crystallizing and purifying the product obtained with ethanol and charcoal. With the new procedure it is possible to reduce the time of obtaining the final product, the reaction becomes endothermic instead of exothermic, which facilitates the work of the operators and allows for the scaling up of the reaction to superior levels. The process significantly decreases the amount of chemicals in the reaction, some of them with toxic properties. Also the environmental negative impact from the process is diminished as the emission of the bromine vapors and other substances to the environment are eliminated and the residual liquids are cut in half.
    本发明是指一种以 2-硝基乙烯基呋喃为原料,通过一个反应步骤获得和纯化 2-溴-5-(2-溴-2-硝基乙烯基)-呋喃,并保持高纯度指标和适当收率的新工艺。 该工艺包括在反应开始时使用木炭直接溴化 2-硝基乙烯基呋喃,然后使用吡啶中和并脱氢溴化,最后使用乙醇和木炭结晶并纯化得到的产物。 采用新工艺可以缩短获得最终产品的时间,反应由放热变为内热,从而方便了操作人员的工作,并使反应规模达到更高水平。 该工艺大大减少了反应中化学物质的用量,其中一些化学物质具有毒性。此外,由于消除了向环境排放溴蒸汽和其他物质,残留液体也减少了一半,该工艺对环境的负面影响也随之降低。
  • An Improved, Fully Heterogeneous, Diastereoselective Synthesis of (Z)-α-Bromonitroalkenes
    作者:Roberto Ballini、Alessandro Palmieri、Serena Gabrielli
    DOI:10.1055/s-0032-1317695
    日期:——
    alpha-Bromonitroalkenes are both key starting materials for the preparation of complex structures and possess antimicrobial activity. In this context, we disclose a simple, fully heterogeneous synthetic approach for their preparation in good overall yields.
查看更多

同类化合物

试剂2,5-Dibromo-3,4-dihexylthiophene 苯-1,2,4-三羧酸-丙烷-1,2,3-三醇(1:1) 碘吡咯 癸氯-二茂铁 溴代二茂铁 溴-(3-溴-2-噻嗯基)镁 派瑞林D 派瑞林 F 二聚体 氯代二茂铁 曲洛酯 异噻唑,3-氯-5-甲基- 地茂酮 四碘噻吩 四溴噻吩 四溴吡咯 四溴-N-甲基吡咯 四氯噻吩 四氟噻吩 噻菌腈 噻美尼定. 噻吩,3-溴-4-(1-辛炔基)- 噻吩,2,5-二氯-3,4-二(氯甲基)- 喷贝特 咪唑烷,2-(4-溴-5-甲基-2-呋喃基)-1,3-二甲基- 叔丁基2-溴-4,6-二氢-5H-吡咯并[3,4-D]噻唑-5-羧酸酯 叔-丁基2-溴-5,6-二氢咪唑并[1,2-A]吡嗪-7(8H)-甲酸基酯 八氟联苯烯 八氟二苯并硒吩 二苯基氯化碘盐 二联苯碘硫酸盐 二氯对二甲苯二聚体 二氯[2-甲基-3(2H)-异噻唑酮-O]的钙合物 二氯-1,2-二硫环戊烯酮 二-(3-溴-1,2,4-噻二唑-5-基)-二硫醚 二(2-噻吩基)碘鎓 [四丁基铵][Δ-三(四氯-1,2-苯二醇酸根)磷酸盐(V)] [3-(4-氯-3,5-二甲基-1H-吡唑-1-基)丙基]胺 [3-(4-氯-1H-吡唑-1-基)-2-甲基丙基]胺 [2-(4-溴-吡唑-1-基)-乙基]-二甲胺 [1-(4-溴-3-甲基-1,2-噻唑-5-基)乙亚基氨基]硫脲 [1-(4-溴-1,2-噻唑-3-基)乙亚基氨基]硫脲 [1,1'-联苯]-2,2'-二基碘鎓 [(4-碘-1,2-噻唑-5-基)亚甲基氨基]硫脲 [(4-氯-1,2-噻唑-5-基)亚甲基氨基]硫脲 N-苄基-2-氯吡咯 N-Boc-2-氨基-3-溴噻吩 N-(2-氯-4-甲基-3-噻吩)-4,5-二氢-1H-咪唑-2-胺盐酸盐 N-(2,5-二溴-1H-吡咯-1-基)-氨基甲酸叔丁酯 N,N-二甲基-5-碘-1H-吡唑-1-磺酰胺 N,N-二甲基-2-(3,4,5-三溴吡唑-1-基)丙酰胺